Toggle Offcanvas
...
 
Dupilumab Tenders

Dupilumab Tenders

View Dupilumab tenders, RFPs and contracts. Bid on readily available Dupilumab tenders with the best and most comprehensive tendering platform, since 2002.

Bidding for Dupilumab tenders is extremely lucrative for companies of all sizes. Tendering authorities and private companies release thousands of contracts worth millions for procurement of Dupilumab.

Global Tenders stands out as the largest platform dedicated to pharmaceutical tenders and government contracts. Boasting over 20 years of experience in the tender business, GlobalTenders offers the most extensive and reliable Tenders/RFPs/Contracts Database available. The platform aggregates contracts from both public and private sources, connecting with a vast network of over half a million buyers. Employing advanced artificial intelligence, our meticulous process involves gathering information from over a hundred thousand sources. The data is then intelligently categorized into thousands of subcategories for easy filtering and presenting it in a user-friendly format for quick comprehension.

In addition to tender information, we offer in-depth Dupilumab market analysis, bid consultancy services, and insights into top bidders and winners.

Sign up now to get instant access to unlimited Dupilumab tenders, advanced search filters, market analysis, industry trends, tender training and 24/7 customer support.

10 Live Notices for Dupilumab Tenders

Showing 1 to 10

* Price Registration * Price Registration For The Supply Of Dupilumab 200 Mg Subcutaneous.
country Brazil
posting date10 Feb 2025
deadline20 Feb 2025
Subject: Electronic Auction - Acquisition Of Medicines To Meet Judicial And Administrative Demands.
country Brazil
posting date04 Feb 2025
deadline19 Feb 2025
Object: Electronic Auction - Large Judicial Medicines
country Brazil
posting date04 Feb 2025
deadline19 Feb 2025
Medicines With The Active Ingredient Dupilumab (Atc: D11Ah05)
country Germany
posting date23 Apr 2024
deadline31 Mar 2026
Medicines With The Active Ingredient Dupilumab (Atc: D11Ah05)
country Germany
posting date20 Apr 2024
deadline31 Mar 2026
Completion Of A Non-Exclusive Discount Contract According To Section 130C Paragraph 1 Sgb V For Dupilumab, Atc Code: D11Ah05 For The Period From December 1St, 2023 To November 30Th, 2025
country Germany
posting date03 Nov 2023
deadline03 Oct 2025
Conclusion Of Non-Exclusive Discount Agreements According To § 130A Abs. 8 Sgb V For The Active Ingredient Dupilumab
country Germany
posting date22 Aug 2023
deadline11 Aug 2025
Conclusion Of Non-Exclusive Discount Agreements According To § 130A Abs. 8 Sgb V For The Active Ingredient Dupilumab
country Germany
posting date21 Aug 2023
deadline11 Aug 2025
Conclusion Of A Non-Exclusive Discount Agreement According To § 130A Para. 8 Sgb V For The Active Ingredient Dupilumab, Atc D11Ah05 For The Period May 1St, 2023 - April 30Th, 2025
country Germany
posting date20 Mar 2023
deadline05 Mar 2025
Conclusion Of A Non-Exclusive Discount Agreement According To § 130A Para. 8 Sgb V For The Active Ingredient Dupilumab, Atc D11Ah05 For The Period May 1St, 2023 - April 30Th, 2025
country Germany
posting date18 Mar 2023
deadline05 Mar 2025

Share Share this page